Electronic structures and reactivity aspects of ruthenium-nitrosyls

Nitrosyl complexes with {Ru-NO}⁶ (4(ClO₄)₃) and {Ru-NO}⁷ (4(ClO₄)₂) configurations have been isolated in the selective molecular framework of [Ru(tpm)(pap)(NO)]ⁿ⁺ (tpm = tris(1-pyrazolyl)methane and pap = 2-phenylazopyridine). The DFT optimized structures of [Ru^II(tpm)(pap)(NO⁺)]³⁺ (4³⁺) and [Ru^II(tpm)(pap)(NO)]²⁺ (4²⁺) predict that the Ru-N-O groups in the complexes are in almost linear and bent geometries, respectively. In agreement with largely NO centered reduction a sizeable shift in ν(NO) frequency of 324 cm⁻¹ has been observed on moving from {Ru^II-NO⁺} state in 4³⁺ to {Ru^II-NO) state in 4²⁺. The DFT proposed NO centered spin in {Ru^II-NO) (4²⁺) (Mulliken spin-densities: 0.860 (NO) and 0.087 (Ru)) has been evidenced by its free radical EPR spectrum with g = 1.989. The strongly electrophilic {Ru^II-NO⁺} state in 4³⁺ (ν(NO): 1962 cm⁻¹) can be transformed to the corresponding complex (3⁺) in the presence of nucleophile, OH⁻ with k = 2.03 × 10⁻¹ M⁻¹ s⁻¹ at 298 K in CH₃CN. On irradiation with light the acetonitrile solution of [Ru^II(tpm)(pap)(NO⁺)]³⁺ (4³⁺) undergoes facile photorelease of NO (k_NO, s⁻¹ = 0.1 × 10⁻¹ and t_1/2, s = 69.3) with the concomitant formation of the solvate [Ru^II(tpm)(pap)(CH₃CN)]²⁺ (2²⁺). The photoreleased NO can be trapped as an Mb-NO adduct.     

Ruthenium(II) mixed-ligand complex containing 2-(4'-benzyloxy-phenyl)imidazo[4,5-f][1,10]phenanthroline: synthesis, DNA-binding and photocleavage studies

A novel polypyridyl ligand 2-(4'-benzyloxyphenyl)imidazo[4,5-f][1,10]phenanthroline (BPIP) and its complex [Ru(bpy)2(BPIP)]2+ (1) (bpy=2,2'-bipyridine) and (2) [Ru(phen)2(BPIP)]2+) (phen=1,10-phenanthroline) have been synthesized and characterized by elemental analysis, electrospray mass spectra and 1H NMR. The DNA-binding properties of the two complexes were investigated by spectroscopic and viscosity measurements. The results suggest that both complexes bind to DNA via an intercalative mode. Both complexes can enantioselectively interact with calf thymus DNA (CT-DNA) in a way. The Lambda enantiomer of complex 1 is slightly predominant for binding to CT-DNA to the Delta enantiomer. Under irradiation at 365 nm, both complexes have also been found to promote the photocleavage of plasmid pBR 322 DNA. Inhibitors studies suggest that singlet oxygen ((1)O2) and hydroxyl radical (*OH) play a significant role in the cleavage mechanism for both complexes. Moreover, the DNA-binding and photocleavage properties of both complexes were compared with that of [Ru(bpy)2(BPIP)]2+ and [Ru(phen)2(BPIP)]2+. The experimental results indicate that methene group existence or not have a significant effect on the DNA-binding and cleavage mechanism of these complexes.     

Ruthenium(II) complexes containing asymmetric 2-(pyrazin-2-yl)naphthoimidazole: syntheses, characterization, DNA-binding and photocleavage studies

A novel asymmetric bidentate ligand, 2-(pyrazin-2-yl)naphthoimidazole (PZNI), and its Ru(II) complexes [Ru(bpy)₂(PZNI)]²⁺ (1) and [Ru(phen)₂(PZNI)]²⁺ (2) have been synthesized and characterized by elemental analysis, mass spectra, ¹H NMR, and electronic spectroscopy. The electrochemical behaviors of the novel complexes were studied by cyclic voltammetry. The DNA-binding properties of the complexes were investigated by spectroscopic methods and viscosity measurements. The experimental results indicate that the complexes 1 and 2 interact with calf thymus DNA by intercalative mode via the terminal naphthyl ring into the base pairs of DNA. The two Ru(II) complexes have also been found to promote the cleavage of plasmid pBR 322 DNA from the supercoiled form I to the open circular form II upon irradiation.     

Light induced DNA scission by a luminescent mixed-ligand uranyl complex

Efficient cleavage of supercoiled pBR322 DNA by X-ray crystallographically characterized complex, [UO₂(phen)(aba)(OC₂H₅)] (phen = 1,10-phenanthroline; aba = 4-dimethylamino benzoate) has been observed on irradiation with UV (350 nm) or visible light without any external additives through a mechanistic pathway involving singlet oxygen. This complex having 1,10-phenanthroline as an intercalator/binder to supercoiled DNA and N,N-(dimethylamino)benzoate as a chromophore.     

Targeting topoisomerase II with the chiral DNA-intercalating ruthenium(II) polypyridyl complexes

Many antitumor drugs act as topoisomerase inhibitors, and the inhibitions are usually related to DNA binding. Here we designed and synthesized DNA-intercalating Ru(II) polypyridyl complexes Δ--[Ru(bpy)₂(uip)]²⁺ and Λ-[Ru(bpy)₂(uip)]²⁺ (bpy is 2,2′-bipyridyl, uip is 2-(5-uracil)-1H-imidazo[4,5-f][1,10]phenanthroline). The DNA binding, photocleavage, topoisomerase inhibition, and cytotoxicity of the complexes were studied. As we expected, the synthesized Ru(II) complexes can intercalate into DNA base pairs and cleave the pBR322 DNA with high activity upon irradiation. The mechanism studies reveal that singlet oxygen (¹O₂) and superoxide anion radical (O₂^•−) may play an important role in the photocleavage. The inhibition of topoisomerases I and II by the Ru(II) complexes has been studied. The results suggest that both complexes are efficient inhibitors towards topoisomerase II by interference with the DNA religation and direct topoisomerase II binding. Both complexes show antitumor activity towards HELA, hepG2, BEL-7402, and CNE-1 tumor cells. Electronic supplementary material The online version of this article (doi:) contains supplementary material, which is available to authorized users.